tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
The FlyMesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
3d ago
MESO
Mesoblast Secures Seven-Year FDA Orphan-Drug Exclusivity for Ryoncil®
PremiumCompany Announcements
Mesoblast Secures Seven-Year FDA Orphan-Drug Exclusivity for Ryoncil®
3d ago
JPMorgan Acquires Substantial Stake in Mesoblast Limited
PremiumCompany Announcements
JPMorgan Acquires Substantial Stake in Mesoblast Limited
4d ago
JPMorgan Ceases Substantial Holding in Mesoblast Limited
PremiumCompany Announcements
JPMorgan Ceases Substantial Holding in Mesoblast Limited
9d ago
State Street Corporation Ceases Substantial Holding in Mesoblast Limited
PremiumCompany Announcements
State Street Corporation Ceases Substantial Holding in Mesoblast Limited
11d ago
Mesoblast Limited Announces New Substantial Holder
PremiumCompany AnnouncementsMesoblast Limited Announces New Substantial Holder
16d ago
Mesoblast Expands U.S. Market with Ryoncil® Launch and Advances Other Therapies
Premium
Company Announcements
Mesoblast Expands U.S. Market with Ryoncil® Launch and Advances Other Therapies
18d ago
Mesoblast Limited Appoints New Director Lyn Cobley
Premium
Company Announcements
Mesoblast Limited Appoints New Director Lyn Cobley
19d ago
Mesoblast Strengthens Board with Financial Expert Lyn Cobley
PremiumCompany Announcements
Mesoblast Strengthens Board with Financial Expert Lyn Cobley
19d ago
Mesoblast Limited Announces Director’s Interest Change
PremiumCompany Announcements
Mesoblast Limited Announces Director’s Interest Change
24d ago
Mesoblast Expands Ryoncil Coverage to Over 100 Million US Lives
PremiumCompany Announcements
Mesoblast Expands Ryoncil Coverage to Over 100 Million US Lives
1M ago
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
PremiumThe Fly
Mesoblast extends payer coverage for Ryoncil to over 100M U.S. lives
1M ago
MESO
Mesoblast Limited Announces Cessation of Securities
PremiumCompany AnnouncementsMesoblast Limited Announces Cessation of Securities
1M ago
Mesoblast Limited Issues Over 8 Million New Securities
Premium
Company Announcements
Mesoblast Limited Issues Over 8 Million New Securities
1M ago
Mesoblast Limited Announces Quotation of New Securities
Premium
Company Announcements
Mesoblast Limited Announces Quotation of New Securities
1M ago
Mesoblast Limited Issues New Equity Securities Under Employee Incentive Scheme
PremiumCompany Announcements
Mesoblast Limited Issues New Equity Securities Under Employee Incentive Scheme
1M ago
Mesoblast Limited Announces Director’s Change in Securities Interest
PremiumCompany Announcements
Mesoblast Limited Announces Director’s Change in Securities Interest
1M ago
Mesoblast Limited Issues New Equity Securities for Employee Incentive
PremiumCompany Announcements
Mesoblast Limited Issues New Equity Securities for Employee Incentive
1M ago
Mesoblast Products Exempt from U.S. Tariffs, Strengthening Market Position
PremiumCompany Announcements
Mesoblast Products Exempt from U.S. Tariffs, Strengthening Market Position
1M ago
Mesoblast Seeks FDA Meeting for Accelerated Approval of Revascor
PremiumCompany AnnouncementsMesoblast Seeks FDA Meeting for Accelerated Approval of Revascor
2M ago
Mesoblast Secures Medicaid Coverage for Ryoncil, Expanding Access for Pediatric Patients
Premium
Company Announcements
Mesoblast Secures Medicaid Coverage for Ryoncil, Expanding Access for Pediatric Patients
2M ago
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
Premium
The Fly
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
2M ago
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >